Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Oct 27;11(11):2121.
doi: 10.3390/antiox11112121.

Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin

Affiliations
Review

Pharmacological Activity, Pharmacokinetics, and Clinical Research Progress of Puerarin

Di Wang et al. Antioxidants (Basel). .

Abstract

As a kind of medicine and food homologous plant, kudzu root (Pueraria lobata (Willd.) Ohwi) is called an "official medicine" in Chinese folk medicine. Puerarin is the main active component extracted from kudzu root, and its structural formula is 8-β-D-grapes pyranose-4, 7-dihydroxy isoflavone, with a white needle crystal; it is slightly soluble in water, and its aqueous solution is colorless or light yellow. Puerarin is a natural antioxidant with high health value and has a series of biological activities such as antioxidation, anti-inflammation, anti-tumor effects, immunity improvement, and cardio-cerebrovascular and nerve cell protection. In particular, for the past few years, it has also been extensively used in clinical study. This review focuses on the antioxidant activity of puerarin, the therapy of diverse types of inflammatory diseases, various new drug delivery systems of puerarin, the "structure-activity relationship" of puerarin and its derivatives, and pharmacokinetic and clinical studies, which can provide a new perspective for the puerarin-related drug research and development, clinical application, and further development and utilization.

Keywords: anti-inflammation; antioxidation; clinical studies; new drug delivery systems; pharmacokinetic; pharmacological activities; puerarin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Partial mechanism of puerarin alleviating oxidative stress [9,11,12,13].
Figure 2
Figure 2
Mechanism of puerarin in improving ALI inflammation caused by gunpowder smog [45].
Figure 3
Figure 3
Mechanism of puerarin inhibiting the expression of pro-inflammatory cytokine IL-6 [64].
Figure 4
Figure 4
The mechanism of puerarin preventing cardiac fibrosis [99].
Figure 5
Figure 5
The mechanism of puerarin on immune cells.
Figure 6
Figure 6
Chemical structures of a series of puerarin derivatives [137,138,139,140,141,142,143].

Similar articles

Cited by

References

    1. Wang J., Ge S., Wang Y., Liu Y., Qiu L., Li J., Huang X., Sun L. Puerarin Alleviates UUO-Induced Inflammation and Fibrosis by Regulating the NF-κB P65/STAT3 and TGFβ1/Smads Signaling Pathways. Drug Des. Devel. Ther. 2021;15:3697–3708. doi: 10.2147/DDDT.S321879. - DOI - PMC - PubMed
    1. Liang W., Li X., Yao Y., Meng Q., Wu X., Wang H., Xue J. Puerarin: A Potential Therapeutic for Colon Adenocarcinoma (COAD) Patients Suffering From SARS-CoV-2 Infection. Front. Pharmacol. 2022;13:921517. doi: 10.3389/fphar.2022.921517. - DOI - PMC - PubMed
    1. Chang B.Y., Lee D.S., Lee J.K., Kim Y.C., Cho H.K., Kim S.Y. Protective activity of kudzu (Pueraria thunbergiana) vine on chemically-induced hepatotoxicity: In vitro and in vivo studies. BMC Complement. Altern. Med. 2016;16:39. doi: 10.1186/s12906-016-1023-2. - DOI - PMC - PubMed
    1. Yu L., Gao F., Yang L., Xu L., Wang Z., Ye H. Biotransformation of puerarin into puerarin-6″-O-phosphate by Bacillus cereus. J. Ind. Microbiol. Biotechnol. 2012;39:299–305. doi: 10.1007/s10295-011-1031-7. - DOI - PubMed
    1. Xia D.Z., Zhang P.H., Fu Y., Yu W.F., Ju M.T. Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial. Food Chem. Toxicol. 2013;59:90–95. doi: 10.1016/j.fct.2013.05.055. - DOI - PubMed